Literature DB >> 1587615

Preliminary characterization of Pseudomonas aeruginosa peptide chemotactins for polymorphonuclear leukocytes.

P A Fontán1, C R Amura, V E García, M C Cerquetti, D O Sordelli.   

Abstract

In a previous report, we showed that supernatants of Pseudomonas aeruginosa cultures exhibit chemotactic activity for polymorphonuclear leukocytes (PMNL). In this study, P. aeruginosa chemotactins were isolated, purified, and partially characterized. The organisms were cultured in Vogel-Bonner defined medium, and cultures were stopped in late log phase. Chemotactins withstood heating, remained unaltered after acid or alkali treatment in a pH range from 4 to 10, and resisted digestion by trypsin or carboxypeptidase, but chemotactic activity was decreased by 73% after incubation with pronase. Only 2% of the total chemotactic activity of culture supernatants could be extracted with chloroform. Chemotactins with molecular sizes less than 3 kDa constituted the largest contribution to the chemotactic activity of culture supernatants. Pretreatment of PMNL with 10(-5) M formylmethionyl-leucyl-phenylalanine (FMLP) inhibited chemotaxis towards FMLP and P. aeruginosa culture supernatants but not towards complement component C5a. In conclusion, the total chemotactic activity for PMNL of P. aeruginosa culture supernatants was due, almost exclusively, to chemotactins that have properties similar, if not identical, to those exhibited by formylmethionyl peptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587615      PMCID: PMC257182          DOI: 10.1128/iai.60.6.2465-2469.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Neutrophil activation by recombinant cytokines.

Authors:  M J Steinbeck; J A Roth
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

Review 2.  The chemotactic peptide receptor. A model for future understanding of chemotactic disorders.

Authors:  R A Allen; A E Traynor; G M Omann; A J Jesaitis
Journal:  Hematol Oncol Clin North Am       Date:  1988-03       Impact factor: 3.722

Review 3.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Laminin promotes the oxidative burst in human neutrophils via increased chemoattractant receptor expression.

Authors:  M C Pike; M S Wicha; P Yoon; L Mayo; L A Boxer
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

5.  Neutrophil-mediated pulmonary vascular injury. Synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung.

Authors:  G S Worthen; C Haslett; A J Rees; R S Gumbay; J E Henson; P M Henson
Journal:  Am Rev Respir Dis       Date:  1987-07

6.  Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo.

Authors:  V S Chadwick; D M Mellor; D B Myers; A C Selden; A Keshavarzian; M F Broom; C H Hobson
Journal:  Scand J Gastroenterol       Date:  1988-01       Impact factor: 2.423

7.  Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.

Authors:  D O Sordelli; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

8.  Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung.

Authors:  D O Sordelli; B J Zeligs; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Eur J Respir Dis       Date:  1985-01

9.  Staphylococcus aureus tetrapeptide with high chemotactic potency and efficacy for human leukocytes.

Authors:  A Rot; L E Henderson; R Sowder; E J Leonard
Journal:  J Leukoc Biol       Date:  1989-02       Impact factor: 4.962

10.  Lipopolysaccharide releases a priming substance from platelets that augments the oxidative response of polymorphonuclear neutrophils to chemotactic peptide.

Authors:  G G Wright; P W Read; G L Mandell
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

View more
  7 in total

1.  Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro.

Authors:  D R Cundell; K Kanthakumar; G W Taylor; W E Goldman; T Flak; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

2.  Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells.

Authors:  B Sar; K Oishi; A Wada; T Hirayama; K Matsushima; T Nagatake
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Piroxicam-copper complexes: inhibition of polymorphonuclear leukocyte migration to Pseudomonas aeruginosa chemotactins in vivo and superoxide dismutase-like activity in vitro.

Authors:  D O Sordelli; P A Fontán; C R Amura
Journal:  Agents Actions       Date:  1993-03

4.  Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4.

Authors:  A Buret; M Dunkley; R L Clancy; A W Cripps
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

5.  Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.

Authors:  P P Massion; H Inoue; J Richman-Eisenstat; D Grunberger; P G Jorens; B Housset; J F Pittet; J P Wiener-Kronish; J A Nadel
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

6.  The effect of a cyclooxygenase inhibitor on the in vivo polymorphonuclear leukocyte migration to Pseudomonas aeruginosa peptide chemotactins.

Authors:  P A Fontán; C R Amura; D O Sordelli
Journal:  Agents Actions       Date:  1993-09

7.  Chemotaxis to oligopeptides by Pseudomonas aeruginosa.

Authors:  K Kelly-Wintenberg; T C Montie
Journal:  Appl Environ Microbiol       Date:  1994-01       Impact factor: 4.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.